Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate

American Journal of Surgical Pathology

Volumn 31, Issue 6, 2007, Pages 889-894

  Herawi, Mehsati ^a   Epstein, Jonathan I ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Acinar adenocarcinoma; AMACR; Cribriform adenocarcinoma; Gleason pattern 4; HMWCK; Immunohistochemical staining; p63; Prostatic duct adenocarcinoma

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CYTOKERATIN; HIGH MOLECULAR WEIGHT CYTOKERATIN; PROTEIN P63; UNCLASSIFIED DRUG; ALPHA-METHYLACYL-COA RACEMASE; ANTIBODY; CKAP4 PROTEIN, HUMAN; DIAGNOSTIC AGENT; ISOMERASE; KERATIN; MEMBRANE PROTEIN; TUMOR MARKER;

ACINAR CELL CARCINOMA; ARTICLE; BASAL CELL; CANCER CLASSIFICATION; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; ADENOCARCINOMA; METABOLISM; PROSTATE TUMOR;

ADENOCARCINOMA; ANTIBODIES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MEMBRANE PROTEINS; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 34447311967     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000213447.16526.7f     Document Type: Article

References (30)

1. Beach R, Gown AM, De Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 2002;26:1588-1596.
2. Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy: correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol. 1999;23:1471-1479.
3. Bock BJ, Bostwick DG. Does prostatic ductal adenocarcinoma exist? Am J Surg Pathol. 1999;23:781-785.
4. Bostwick DG, Kindrachuk RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features. Clinical, pathologic, and ultrastructural findings. Am J Surg Pathol. 1985;9:595-609.
5. Christensen WN, Steinberg G, Walsh PC, et al. Prostatic duct adenocarcinoma. Findings at radical prostatectomy. Cancer. 1991;67:2118-2124.
6. Cohen RJ, McNeal JE, Baillie T. Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression. Prostate. 2000;43:11-19.
7. Dawkins HJ, Sellner LN, Turbett GR, et al. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Prostate. 2000;44:265-270.
8. Epstein JI, Yang XM. Prostate Biopsy Interpretation. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002:56-60 and 185-197.
9. Farinola MA, Epstein JI. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol. 2004;35:1272-1278.
10. Greene LF, Farrow GM, Ravits JM, et al. Prostatic adenocarcinoma of ductal origin. J Urol. 1979;121:303-305.
11. Guo CC, Epstein JI. Intraductal carcinoma of the prostate: histologic features and clinical significance. Mod Pathol. 2006;19:1528-1535.
12. Hedrick L, Epstein JI. Use of keratin 903 as an adjunct in the diagnosis of prostate carcinoma. Am J Surg Pathol. 1989;13:389-396.
13. Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397-1404.
14. Jiang Z, Li C, Fischer A, et al. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol. 2005;123:231-236.
15. Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic carcinoma. Cancer. 1985;56:1566-1573.
16. Kronz JD, Shaikh AA, Epstein JI. Atypical cribriform lesions on prostate biopsy. Am J Surg Pathol. 2001;25:147-155.
17. Magi-Galluzzi C, Luo J, Isaacs WB, et al. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol. 2003;27:1128-1133.
18. McNeal JE, Reese JH, Redwine EA, et al. Cribriform adenocarcinoma of the prostate. Cancer. 1986;58:1714-1719.
19. McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol. 1996;20:802-814.
20. Millar EK, Sharma NK, Lessells AM. Ductal (endometrioid) adenocarcinoma of the prostate: a clinicopathological study of 16 cases. Histopathology. 1996;29:11-19.
21. Oliai BR, Kahane H, Epstein JI. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34 beta E12) antibody. Am J Surg Pathol. 2002;26:1151-1160.
22. Ro JY, Ayala AG, Wishnow KI, et al. Prostatic duct adenocarcinoma with endometrioid features: immunohistochemical and electron microscopic study. Semin Diagn Pathol. 1988;5:301-311.
23. Rubin MA, de La Taille A, Bagiella E, et al. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. Am J Surg Pathol. 1998;22:840-848.
24. Samaratunga H, Singh M. Distribution pattern of basal cells detected by cytokeratin 34 beta E12 in primary prostatic duct adenocarcinoma. Am J Surg Pathol. 1997;21:435-440.
25. Sanderson SO, Sebo TJ, Murphy LM, et al. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays. Am J Clin Pathol. 2004;121:220-225.
26. Shah RB, Kunju LP, Shen R, et al. Usefulness of basal cell cocktail (34betaE12+p63) in the diagnosis of atypical prostate glandular proliferations. Am J Clin Pathol. 2004;122:517-523.
27. Wojno KJ, Epstein JI. The utility of basal cell-specific anticytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases. Am J Surg Pathol. 1995;19:251-260.
28. Zhou M, Shah R, Shen R, et al. Basal cell cocktail (34betaE12+p63) improves the detection of prostate basal cells. Am J Surg Pathol. 2003;27:365-371.
29. Zhou M, Jiang Z, Epstein JI. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Am J Surg Pathol. 2003;27:772-778.
30. Zhou M, Aydin H, Kanane H, et al. How often does alphamethylacyl-CoA- racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol. 2004;28:239-243.